Dose‐intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients
Sarah Farag(University of Bern), Thomas Pabst(University Hospital of Bern), Barbara Jeker(University of Bern), Urban Novak(University of Bern), Behrouz Mansouri Taleghani(University of Bern), Ulrike Bacher(Hattiesburg Clinic), Beatrice U. Mueller
Cited by 15
Related Papers
Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients
|Blood|2007|410
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)
|Journal of Clinical Oncology|2004|300
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
|Blood|2010|189